Literature DB >> 2430154

Sickle cell disease in Orissa State, India.

B C Kar, R K Satapathy, A E Kulozik, M Kulozik, S Sirr, B E Serjeant, G R Serjeant.   

Abstract

A study of 131 patients with homozygous sickle cell (SS) disease in Orissa State, India, indicated that, compared with Jamaican patients, Indian patients have higher frequencies of alpha thalassaemia, higher fetal haemoglobin, total haemoglobin, and red cell counts, and lower mean cell volume, mean cell haemoglobin concentration, and reticulocyte counts. Indian patients have a greater frequency and later peak incidence of splenomegaly, and hypersplenism is common. Painful crises and dactylitis are not uncommon in Indian patients but chronic leg ulceration is rare. Homozygous sickle cell disease in Orissa is similar to that in the Eastern Province of Saudi Arabia and is very different from that in populations of West African origin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430154     DOI: 10.1016/s0140-6736(86)92205-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

Review 1.  Advances in management of sickle cell disease.

Authors:  M B Agarwal
Journal:  Indian J Pediatr       Date:  2003-08       Impact factor: 1.967

Review 2.  Current concerns in haematology. 1. Is the painful crisis of sickle cell disease a "steal" syndrome?

Authors:  G R Serjeant; R M Chalmers
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 3.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

Review 4.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

5.  Transfusion in sickle cell disease: experience from a Gujarat centre.

Authors:  Vishal Mehta; Abhishek Mistry; Bhavesh Raicha; Yazdi Italia; Graham Serjeant
Journal:  Indian J Pediatr       Date:  2013-07-20       Impact factor: 1.967

6.  Newborn screening for sickle cell disease in India: the need for defining optimal clinical care.

Authors:  Jyotish Patel; Graham R Serjeant
Journal:  Indian J Pediatr       Date:  2013-09-14       Impact factor: 1.967

Review 7.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

8.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

9.  The switch from fetal to adult hemoglobin.

Authors:  Vijay G Sankaran; Stuart H Orkin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

10.  Clinical profile of sickle cell disease in Orissa.

Authors:  B C Kar; S Devi
Journal:  Indian J Pediatr       Date:  1997 Jan-Feb       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.